BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2262030)

  • 21. The effects of pretreatment with 7,8-benzoflavone on drug-metabolizing enzymes and diethylstilboestrol metabolism in male hamster liver microsomal preparations.
    Blaich G; Metzler M
    Xenobiotica; 1988 Feb; 18(2):199-206. PubMed ID: 3259760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative potency of mexiletine, lidocaine, and tocainide as inhibitors of rat liver CYP1A1 activity.
    Wei X; Loi CM; Jarvi EJ; Vestal RE
    Drug Metab Dispos; 1995 Dec; 23(12):1335-8. PubMed ID: 8689940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver.
    Sheets JJ; Mason JI
    Drug Metab Dispos; 1984; 12(5):603-6. PubMed ID: 6149911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interspecies features of hepatic cytochromes P450 IA1 and P450 IA2 in rodents.
    Tsyrlov IB; Duzchak TG
    Xenobiotica; 1990 Nov; 20(11):1163-70. PubMed ID: 2275212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro metabolism and covalent binding of ethylbenzene to microsomal protein as a possible mechanism of ethylbenzene-induced mouse lung tumorigenesis.
    Saghir SA; Zhang F; Rick DL; Kan L; Bus JS; Bartels MJ
    Regul Toxicol Pharmacol; 2010; 57(2-3):129-35. PubMed ID: 20096743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism-based inactivation of the major beta-naphthoflavone-inducible isozyme of rat liver cytochrome P-450 by the chloramphenicol analog N-(2-p-nitrophenethyl)dichloroacetamide.
    Miller NE; Halpert JR
    Drug Metab Dispos; 1987; 15(6):846-51. PubMed ID: 2893712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of cytochrome P-450 activity in rat liver microsomes by the naturally occurring flavonoid, quercetin.
    Sousa RL; Marletta MA
    Arch Biochem Biophys; 1985 Jul; 240(1):345-57. PubMed ID: 3925883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triphenyltin acetate-mediated in vitro inactivation of rat liver cytochrome P-450.
    Nebbia C; Ceppa L; Dacasto M; Carletti M
    J Toxicol Environ Health A; 1999 Mar; 56(6):433-47. PubMed ID: 10096365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes.
    Agarwal R; Wang ZY; Bik DP; Mukhtar H
    Drug Metab Dispos; 1991; 19(3):620-4. PubMed ID: 1680628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides.
    Thakker DR; Levin W; Buening M; Yagi H; Lehr RE; Wood AW; Conney AH; Jerina DM
    Cancer Res; 1981 Apr; 41(4):1389-96. PubMed ID: 7194138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
    Grossman SJ; Herold EG; Drey JM; Alberts DW; Umbenhauer DR; Patrick DH; Nicoll-Griffith D; Chauret N; Yergey JA
    Drug Metab Dispos; 1993; 21(6):1029-36. PubMed ID: 7905381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities.
    Astroff B; Zacharewski T; Safe S; Arlotto MP; Parkinson A; Thomas P; Levin W
    Mol Pharmacol; 1988 Feb; 33(2):231-6. PubMed ID: 2828916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of methoxyresorufin demethylase activity by flavonoids in human liver microsomes.
    Zhai S; Dai R; Wei X; Friedman FK; Vestal RE
    Life Sci; 1998; 63(8):PL119-23. PubMed ID: 9718089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of inhibition of CYP1A1 and glutathione S-transferase activities in fish liver by quercetin, resveratrol, naringenin, hesperidin, and rutin.
    Arinç E; Yilmaz D; Bozcaarmutlu A
    Nutr Cancer; 2015; 67(1):137-44. PubMed ID: 25372667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of human estrogen synthetase (aromatase) by flavones.
    Kellis JT; Vickery LE
    Science; 1984 Sep; 225(4666):1032-4. PubMed ID: 6474163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of feeding quercetin and flavone on hepatic drug metabolizing enzymes of rat.
    Siess MH; Brouard C; Vernevaut MF; Suschetet M
    Prog Clin Biol Res; 1988; 280():147-50. PubMed ID: 3140245
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of synthetic and naturally occurring flavonoids on benzo[a]pyrene metabolism by hepatic microsomes prepared from rats treated with cytochrome P-450 inducers.
    Chae YH; Marcus CB; Ho DK; Cassady JM; Baird WM
    Cancer Lett; 1991 Oct; 60(1):15-24. PubMed ID: 1913623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of mammalian epoxide hydrase activity by flavones.
    Alworth WL; Dang CC; Ching LM; Viswanathan T
    Xenobiotica; 1980 Jun; 10(6):395-400. PubMed ID: 7415221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of substituted flavones as gastroprotective agents.
    Ares JJ; Outt PE; Randall JL; Murray PD; Weisshaar PS; O'Brien LM; Ems BL; Kakodkar SV; Kelm GR; Kershaw WC
    J Med Chem; 1995 Dec; 38(25):4937-43. PubMed ID: 8523407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of dietary flavonoids on purified hepatic NADH-cytochrome b5 reductase: structure-activity relationships.
    Çelik H; Koşar M
    Chem Biol Interact; 2012 May; 197(2-3):103-9. PubMed ID: 22542668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.